HIGHLIGHTS
- who: Aiqi Zhao and collaborators from the National Institutes of Health (NIH), United States Department of Hematology, The Second Affiliated Hospital, School of Medicine, University have published the Article: Secondary myeloid neoplasms after CD19 CAR T therapy in patients with refractory/relapsed B-cell lymphoma: Case series and review of literature, in the Journal: (JOURNAL)
- future: In the future further analysis of scRNA-seq data from more t-MDS and pMDS BM samples hold the promise to elucidate how different cell types contribute to t-MDS progression after CAR T therapy and provide directions to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.